Facility visit: Lonza

The Swiss CDMO has opened its manufacturing base in Visp, letting Manufacturing Chemist tour the site and find out what the future holds for the company

picture of

Breaking News

Catalent client gets FDA approval for generic bronchodilator

Approval has marked the first generic metered-dose inhaler to be approved by the FDA in over twenty years and will now ...

Alcami acquires TriPharm Services

US-based Alcami has acquired a new sterile fill-finish company near the Research Triangle Park in North Carolina

PCI expands in Canada with clinical trial services acquisition

Bellwyck Pharma Services has joined US-based PCI’s global network

Zenith on the buzzwords for pharma 2020

Joe Haugh, Zenith Technologies CEO, describes 2019 as a real watershed year, with topics such as Industry 4.0, ...

Catalent signs agreement for first-in-class oncological therapy

Zumutor Biologics has chosen Catalent to provide process optimisation and drug substance manufacturing services

Velesco Pharma opens facility to triple cGMP clinical contract manufacturing

New facility has replaced and consolidated Velesco’s existing manufacturing site

John Baker: Life sciences need to address the reproducibility crisis

The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to ...

Catalent adds to regenerative therapy portfolio with $315m acquisition

Belgian CDMO MaSTherCell Global is a technology-focused cell and gene therapy CDMO

Piramal expands API contract manufacturing in Canada

CAD$25 million has been infused towards a new API manufacturing wing

Integrated solutions offer fast-track development for biopharmaceuticals

At the heart of any successful medicine launch is a robust manufacturing process that will reliably make the product in ...

Super early bird tickets now on sale for Manufacturing Chemist Live 2020

Manufacturing Chemist Live will provide guidelines and regulations for delegates seeking solutions to optimise ...

Lonza reveals process development roadmap for cell and gene therapies

Behnam Baghbaderani of Lonza Pharma & Biotech examines four manufacturing challenges inherent to the production of ...

Genopis plans plasmid CDMO business launch

Helixmith US-based spinout has capitalised on its pDNA manufacturing experience with plans to launch a CDMO business

US gene therapy CDMO enters virus manufacturing partnership

Vigene Biosciences will provide manufacturing services for ASC for both early-stage and commercial virus production